FDA Will Regulate Diagnostic Tests. Yes, Those for Alzheimer’s, Too.

NewsEducation
Written By Emily Scholler
Emily Scholler
Previous

The Global CEO Initiative on Alzheimer’s Disease Comment on the World Health Organization’s Preferred Product Characteristics for Blood Tests for Alzheimer’s Disease
Next

Optimising Alzheimer’s Disease Diagnosis and Treatment: Assessing Cost-Utility of Integrating Blood Biomarkers in Clinical Practice for Disease-Modifying Treatment